Your browser doesn't support javascript.
loading
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy.
Singh, Nirupama; Staves, Julie; Storry, Jill R; Dinoso, Jason; Renard, Camille; Doshi, Parul; Johnson, Lisa D S; Westhoff, Connie M; Murphy, Michael F.
Afiliação
  • Singh N; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Staves J; Oxford University Hospitals, NHS Foundation Trust, Oxford, UK.
  • Storry JR; Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.
  • Dinoso J; Gilead Sciences, Inc, Foster City, California, USA.
  • Renard C; Gilead Sciences, Inc, Foster City, California, USA.
  • Doshi P; Gilead Sciences, Inc, Foster City, California, USA.
  • Johnson LDS; Gilead Sciences, Inc, Foster City, California, USA.
  • Westhoff CM; New York Blood Center Enterprises, Immunohematology and Blood Group Genomics, New York, New York, USA.
  • Murphy MF; NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust and the University of Oxford, Oxford, UK.
Transfusion ; 63(12): 2377-2383, 2023 12.
Article em En | MEDLINE | ID: mdl-37970740
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article